MedPath

The Study of Clinical Efficacy and Safety of Benjakul Remedy in Stage 4 Non Small Cell Lung Cancer

Phase 2
Recruiting
Conditions
Diagnosed with non&#45
small cell lung cancer stage 4&#44
confirmed by pathology and radiology and do not respond to chemotherapy at least two formulas and can not be treated with drugs targetted
Carcinoma&#44
Non&#45
Small&#45
Cell Lung [C04.588.894.797.520.109.220.249]
Registration Number
TCTR20150805001
Lead Sponsor
ational research council of thailand
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
16
Inclusion Criteria

1. Females and males aged 25-70 years
2. Diagnosed with non-small cell lung cancer stage 4, confirmed by pathology and radiology
3. Do not respond to chemotherapy at least two formulas and can not be treated with drugs targetted.
4. Have never used herbs in the treatment of non-small cell lung cancer.
5. ECOG (Eastern Cooperative Oncology Group) performance status performance patients based on a scale of 0 to 2A
6. The following laboratory criteria
6.1 Hemoglobin ≥ 10 grams per deciliter
6.2 Leukocytes ≥ 3.0 x 109 / L
6.3 Lymphocyte Type of neutrophils > 1.5 x 109 / L
6.4 Platelet > 75 x 109 / L
6.5 Aspartate transferase (AST), alanine aminotransferase (ALT), alkaline phosphatase(ALP), bilirubin no more than 3 times that of standard
6.6 Creatinine no more than 1.5 mg per deciliter
7. Patients treated and followed up on schedule.
8. Volunteers must make a conscious decision to participate in the research themselves.
9. Patient understands and signs consent to participate in research.

Exclusion Criteria

1. ECOG Performance status in range the 3 to 5
2. The disease has spread to the brain
3. Has herbal drug allergy
4. Are pregnant or breastfeeding
5. Taking chemotherapy or other herbs during the study
6. Take medicine regularly for peptic ulcer
7. People who have problems swallowing who can not eat the capsule
8. Are participating in other research programs

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath